Kick-Off: The Road to Elimination and the Role of NIH Research

Kick-Off: The Road to Elimination and the Role of NIH Research

March 4 2021
90 minutes
Webinar series
NIH Research Advancing Hepatitis Elimination
Video URL

Kick-off webinar: The road to hepatitis elimination and the role of NIH Research
Thursday, March 4th, 3-4:30 pm

The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination.  In addition to basic research to understand the molecular processes of viral hepatitis infection, NIH focuses on development of new vaccines, diagnostics, treatments and other interventions to prevent acute and chronic hepatitis infection and related disease. In 2020, Dr. Harvey Alter, NIH researcher, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV, exemplifying the importance of NIH to hepatitis elimination efforts.  

With the launch of the Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021-2025  and only 10 years to go to reach global elimination goals, now is the time to bring together the research and implementing strategies to improve hepatitis prevention, testing, and treatment. To facilitate these discussions, NIH and the Coalition for Global Hepatitis Elimination are launching a new webinar series, "Moving from Hepatitis Discovery to Elimination: NIH Research Advancing Hepatitis Elimination." The objectives of the series are to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs. More information is available here.

The first webinar, "The Road to Elimination and the Role of NIH Research" will set the stage on the status of hepatitis elimination efforts globally and in the United States and will introduce hepatitis-related research activities across the NIH institutes. Special introductory remarks will be made by Dr. Harvey Alter, 2020 Nobel Prize Laureate.

Additional presentations and remarks will be made by:

  • Dr. Doug Lowy, Principal Deputy Director, NCI/NIH
  • Dr. John Ward, Director, Coalition for Global Hepatitis Elimination
  • Dr. Carolyn Wester, Director, Division of Viral Hepatitis, US CDC
  • Dr. Judith Steinberg, Chief Medical Officer, Office for Infectious Disease and HIV/AIDS Policy, HHS
  • Dr. Jessica Deerin,  Epidemiologist, Office for Infectious Disease and HIV/AIDS Policy, HHS


Other upcoming webinars


Thursday, April 8th, 3-4:30 pm
Collaborative research on hepatitis C identification and treatment among persons who inject drugs
Hosted by NIDA

Thursday, May 13th, 3-4:30 pm
Leaving no one behind: Research to uncover and address health disparities in hepatitis burden of disease and care
Hosted by NIMDH/OAR

Additional monthly webinars on:
-HCV Vaccine Development: Where do we stand?
-Preventing mother to child transmission of hepatitis
-Improving early detection of HCC: The quest of new biomarkers
-New HCV diagnostic development
-New frontiers for HBV therapy

Contact globalhep [at] taskforce.org for more information.

Dr. Harvey Alter
2020 Nobel Prize Laureate, CC/NIH
Dr. Doug Lowy
Principal Deputy Director, NCI/NIH
Dr. John Ward
Director, Coalition for Global Hepatitis Elimination
Dr. Carolyn Wester
Director, Division of Viral Hepatitis, US CDC
Dr. Judith Steinberg
Chief Medical Officer, OIDHAP/OASH/HHS